| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |